The American Conference Institute (“ACI”) will hold its 26th FDA Boot Camp conference in Boston, Massachusetts from September 30 to October 1, 2015. A copy of the conference program can be obtained here. Hyman, Phelps & McNamara, P.C.’s Kurt R. Karst will co-chair the event with Kleinfeld, Kaplan & Becker, LLP’s Scott M. Lassman. The conference will include presentations from a virtual “who’s who list” of FDA regulatory experts on myriad topics, including the approval process, pre-approval concerns, product labeling, clinical trials, adverse events reporting, and patent and non-patent marketing exclusivity issues.
ACI will also hold its 3rd annual Paragraph IV Disputes Master Symposium in Chicago, Illinois from September 30 to October 1, 2015, with a post-conference workshop on October 2nd. A copy of the conference program can be obtained here. The conference features presentations from preeminent patent litigators representing brand-name and generic drug manufacturers, leading in-house counsel, and esteemed jurists and government representatives who will discuss, analyze, and interpret the latest controversies affecting Paragraph IV litigation. Hyman, Phelps & McNamara, P.C.’s James C. Shehan will be speaking at the conference.
FDA Law Blog is a media partner for both conferences. As such, we can offer FDA Law Blog readers a special $200 discount off the current price tier. The discount code is: FDA200. We look forward to seeing you at the conferences.